11.45
price down icon6.22%   -0.76
after-market Handel nachbörslich: 12.02 0.57 +4.98%
loading

Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
47.31%
60.07
114.00 56.86 - -
Operating Income/Loss
47.31%
-60.07
-114.00 -56.86 - -
Nonoperating Income/Loss
14.63%
6.353
5.542 3.837 - -
Income/Loss From Continuing Operations Before Tax
50.47%
-53.72
-108.46 -53.03 -38.54 -35.62
Income/Loss From Continuing Operations After Tax
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Net Income/Loss
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
433.72%
157.94
29.59 46.69 - -
Diluted Average Shares
433.72%
157.94
29.59 46.69 - -
Basic Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Diluted Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):